Table 3. Characteristics of infections in EAS patients.
Site | No. of patients | Number of patients with infection/ Pathogen |
---|---|---|
Respiratory | 5 | 1.Klebsiella oxytoca, Candida albicans |
1.Klebsiella pneumonia only | ||
3. na | ||
Gastrointestinal tract | ||
• oral cavity | 2 | 1.Cryptoccocus laurentii, |
1.na | ||
• esophagus | 2 | 1.Candida albicans |
1. fungal infection | ||
• small intestine | 1 | 1.Rotavirus |
• liver-AVH | 1 | 1. Hepatitis B and C virus |
Urinary tract | 6 | 1.Enterococcus faecalis, Streptoccocus viridans |
1.Enterococcus faecalis VRE | ||
2.Escherichia coli | ||
1.Enterococcus faecalis HLAR, Escherichia coli, Candida albicans | ||
1.na | ||
Ear/nose | ||
• otitis media | 1 | 1.na |
Central venous catheter | 1 | 1.na |
Cutaneous | ||
acne | 1 | 1.na |
Eye | ||
• bilateral fungal endophthalmitis | 1 | 1.na |
• bacterial conjunctivitis | 1 | 1.na |
Postoperative wound | 3 | 1.Serratia marcescens, Morganella morgani |
1.Staphylococcus epidermidis | ||
1. Escherichia coli ESBL | ||
Central nervous system | 1 | 1.na |
Other | ||
• coxitis fugax | 1 | 1.na |
• suprahepatic abscess | 1 | 1.na |
• abscess in the bursa omentalis | 1 | 1.Enterobacter cloacae ESBL |
• sepsis | 2 | 1. Escherichia coli |
1.Klebasiella pneumoniae ESBL, Escherichia coli |
Abbreviations: na- not available; VRE—Vancomycin-resistant enterococci, HLAR—High-level aminoglycoside resistance; ESBL—Extended spectrum beta-lactamases; AVH—Acute viral hepatitis